Hybrid coronary revascularization: position paper of the European Society of Cardiology Working Group on Cardiovascular Surgery and European Association of Percutaneous Cardiovascular Interventions

Myocardial revascularization in coronary artery disease via percutaneous coronary intervention or coronary artery bypass graft (CABG) surgery effectively relieves symptoms, significantly improves prognosis and quality of life when combined with guideline-directed medical therapy. Hybrid coronary revascularization is a promising alternative to percutaneous coronary intervention or CABG in selected patients and is defined as a planned and/or intended combination of consecutive CABG surgery using at least 1 internal mammary artery to the left anterior descending (LAD), and catheter-based coronary intervention to the non-LAD vessels for the treatment of multivessel disease. The main indications for hybrid coronary revascularization are (i) to achieve complete revascularization in patients who cannot undergo conventional CABG, (ii) to treat patients with acute coronary syndromes and multivessel disease with a non-LAD vessel as the culprit lesion that needs revascularization and (iii) in highly select patients with multivessel disease with complex LAD lesions and simple percutaneous coronary intervention targets for all other vessels. Hybrid coronary revascularization patients receive a left internal mammary artery graft to the LAD artery through a minimal incision along with percutaneous coronary intervention to the remaining diseased coronary vessels using latest generation drug-eluting stents. A collaborative environment with a dedicated heart team is the optimal platform to perform such interventions, which aim to improve the quality and outcome of myocardial revascularization. This position paper analyses the rationale of hybrid coronary revascularization and the currently available evidence on the various techniques and delves into the sequence of the interventions and pharmacological management during and after the procedure.

Authors

Institutions

Publication Details

Journal
European Journal of Cardio-Thoracic Surgery
Published
2024-08-01
DOI
https://doi.org/10.1093/ejcts/ezae271
Citations
11
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
6.30
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hybrid coronary revascularization: position paper of the European Society of Cardiology Working Group on Cardiovascular Surgery and European Association of Percutaneous Cardiovascular Interventions

Nikolaos Bonaros, Fabio Barili, Piotr Suwalski, Claudio Muneretto et al.
11 citations
European Journal of Cardio-Thoracic Surgery
Coronary Interventions and Diagnostics
6.30
article

Hybrid coronary revascularization: position paper of the European Society of Cardiology Working Group on Cardiovascular Surgery and European Association of Percutaneous Cardiovascular Interventions

Nikolaos Bonaros, Fabio Barili, Piotr Suwalski, Claudio Muneretto, Thierry A Folliguet, Matthias Thielmann, Sharaf-Eldin Shehada, Martin Czerny, Alessandro Parolari, Roman Gottardi, Guy Friedrich, Emanuele Barbato, Jacek Legutko, Sigrid Sandner, Prakash P Punjabi, D. Wendt
article en
11 citations

Abstract

Myocardial revascularization in coronary artery disease via percutaneous coronary intervention or coronary artery bypass graft (CABG) surgery effectively relieves symptoms, significantly improves prognosis and quality of life when combined with guideline-directed medical therapy. Hybrid coronary revascularization is a promising alternative to percutaneous coronary intervention or CABG in selected patients and is defined as a planned and/or intended combination of consecutive CABG surgery using at least 1 internal mammary artery to the left anterior descending (LAD), and catheter-based coronary intervention to the non-LAD vessels for the treatment of multivessel disease. The main indications for hybrid coronary revascularization are (i) to achieve complete revascularization in patients who cannot undergo conventional CABG, (ii) to treat patients with acute coronary syndromes and multivessel disease with a non-LAD vessel as the culprit lesion that needs revascularization and (iii) in highly select patients with multivessel disease with complex LAD lesions and simple percutaneous coronary intervention targets for all other vessels. Hybrid coronary revascularization patients receive a left internal mammary artery graft to the LAD artery through a minimal incision along with percutaneous coronary intervention to the remaining diseased coronary vessels using latest generation drug-eluting stents. A collaborative environment with a dedicated heart team is the optimal platform to perform such interventions, which aim to improve the quality and outcome of myocardial revascularization. This position paper analyses the rationale of hybrid coronary revascularization and the currently available evidence on the various techniques and delves into the sequence of the interventions and pharmacological management during and after the procedure.

European Journal of Cardio-Thoracic SurgeryVol. 66(2)
Jagiellonian University (PL), Harvard University (US), Innsbruck Medical University (AT), Imperial College Healthcare NHS Trust (GB), University of Freiburg (DE), University of Milan (IT), Universität Innsbruck (AT), Université Paris-Est Créteil (FR), Hammersmith Hospital (GB), Assistance Publique – Hôpitaux de Paris (FR), Lung Institute (US), Onze Lieve Vrouwziekenhuis Hospital (BE), John Paul II Hospital (PL), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Essen University Hospital (DE), Ministry of Interior and Administration (PL), Cardiovascular Research Center (BR), Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE), Central Clinical Hospital (PL), West German Heart and Vascular Center Essen (DE), Imperial College London (GB), Medical University of Vienna (AT), University of Brescia (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 3%
Coronary Interventions and Diagnostics
6.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.